-
Pfizer's 2Q Revenues Up 92%
contractpharma
July 30, 2021
COVID-19 vaccine BNT162b2 contributes $7.8 billion in sales and alliance revenues.
-
Bristol Myers Squibb revenues increase in Q1 2021
pharmaceutical-technology
May 06, 2021
Bristol Myers Squibb has reported revenues of $11.1bn for the first quarter of this year, which represents an increase of 3%, compared to $10.78bn in the first quarter last year.
-
Pfizer 1Q Revenues up 45% Driven by COVID Vax
contractpharma
May 06, 2021
Vaccine sales were $4.9 billion in the quarter, with BNT162b2 contributing $3.5 billion in global revenues.
-
Financial Report: Amgen
contractpharma
November 06, 2020
Revenues up 12% in the quarter to $6.4 billion.
-
Financial Report; Abbvie
contractpharma
November 02, 2020
Revenue up 52% in the quarter to $12.9 billion.
-
Financial Report: PPD
contractpharma
October 30, 2020
Comments: Clinical Development Services revenue was $1.0 billion in the quarter, up 19% and Laboratory Services revenue was $225.2 million, up 27%.
-
Financial Report: Gilead
contractpharma
October 29, 2020
Comments: HIV Product sales were $4.5 billion, up 8% primarily due to the continued strength of the HIV franchise and Biktarvy share continues to grow in the U.S. HCV Product sales declined 31% to $464 million impacted by delayed patient starts due to ...
-
Financial Report; Lilly
contractpharma
October 29, 2020
Comments: Key growth products launched since 2014, consisting of Taltz, Trulicity, Verzenio, Jardiance, Olumiant, Emgality, Tyvyt, Baqsimi, Cyramza, Retevmo and Basaglar contributed nearly 9 percentage points of revenue growth and represented ...
-
Financial Report: Biogen
contractpharma
October 28, 2020
Commetns: Multiple sclerosis revenues, including $272 million in royalties on sales of OCREVUS, decreased 4%. Total Interferon sales (AVONEX and PLEGRIDY) were down 11% to $474 million.
-
Financial Report, Pfizer
contractpharma
August 13, 2020
Biopharma revenues were $9.8 billion, up 6% operationally, primarily driven by Vyndaqel.